All Posts
The WHO estimates of excess mortality associated with the COVID-19 pandemic
9 Jan, 2023 | 14:48h | UTCThe WHO estimates of excess mortality associated with the COVID-19 pandemic – Nature
Commentary: Pandemic’s Two-Year Global Death Toll May Be Close to 15 Million – HealthDay
Scientists tie third clinical trial death to experimental Alzheimer’s drug
9 Jan, 2023 | 14:47h | UTCScientists tie third clinical trial death to experimental Alzheimer’s drug – Science
Related: RCT | Lecanemab slows cognitive decline in early Alzheimer’s disease but raises safety concerns.
ESC/AHA/ACC/WHF Joint Opinion | Randomized trials fit for the 21st century
9 Jan, 2023 | 14:44h | UTCCommentaries:
It’s Time to Revamp How Clinical Trials Are Done, Say Cardiology Societies – TCTMD
Commentary on Twitter
Together with @ACCinTouch @escardio & @worldheartfed, we are positioned to push, guide and support the remodeling of #RCTs for the 21st century. #RedesignRCTs
Read the joint statement in @circaha: https://t.co/hoypaSp10m pic.twitter.com/vwMGx0tksz
— AHA Science (@AHAScience) December 16, 2022
Consensus Guideline | Management of the perioperative patient on cannabis and cannabinoids
9 Jan, 2023 | 14:43h | UTC
Commentary on Twitter
https://twitter.com/ASRA_Society/status/1610269709374554114
ASCO Guideline | Immunotherapy and targeted therapy for advanced gastroesophageal cancer
9 Jan, 2023 | 14:40h | UTC
ASCO Guideline | Immunotherapy and biomarker testing in recurrent and metastatic head and neck cancers
9 Jan, 2023 | 14:41h | UTCNews Release: ASCO Publishes New Guideline on Immunotherapy, Biomarker Testing in Advanced Head and Neck Cancer – ASCO Daily News
Cohort Study | Association of habitual checking behaviors on social media with longitudinal functional brain development
9 Jan, 2023 | 14:38h | UTCAssociation of Habitual Checking Behaviors on Social Media With Longitudinal Functional Brain Development – JAMA Pediatrics (link to abstract – $ for full-text)
Commentaries:
Social Media Checking Behaviors in Teens Linked to Brain Changes – HealthDay
For adolescents, social media might be a brain-changer, researchers say – CNN
M-A | Physical activity interventions to alleviate depressive symptoms in children and adolescents
9 Jan, 2023 | 14:37h | UTCPhysical Activity Interventions to Alleviate Depressive Symptoms in Children and Adolescents: A Systematic Review and Meta-analysis – JAMA Pediatrics (link to abstract – $ for full-text)
Commentary: Exercise, Sports: A Natural Antidepressant for Teens – HealthDay
Commentary on Twitter
The results of this systematic review and meta-analysis suggest that physical activity interventions can alleviate symptoms of depression in children and adolescents. https://t.co/7P6gWPf35K
— JAMA Pediatrics (@JAMAPediatrics) January 3, 2023
The year in cardiovascular medicine 2022: the top 10 papers in acute cardiac care and ischemic heart disease
9 Jan, 2023 | 14:28h | UTC
Commentary on Twitter
The Year in Cardiovascular Medicine 2022 series: the Top 10 papers in Cardiovascular Imaging https://t.co/OVJxxYu71p@escardio #EHJ #ESCYoung #cardiotwitter @ehj_ed @rladeiraslopes #CVD #cvimaging @chiarabd @NAjmoneMarsan pic.twitter.com/sooF0bz3LN
— European Society of Cardiology Journals (@ESC_Journals) January 2, 2023
The year in cardiovascular medicine 2022: the top 10 papers in dyslipidemias
9 Jan, 2023 | 14:26h | UTC
Commentary on Twitter
The Year in Cardiovascular Medicine 2022 series: the Top 10 papers in Dyslipidaemia https://t.co/jpkqgt4Hf1 @escardio #EHJ #ESCYoung #cardiotwitter @ehj_ed @rladeiraslopes #CVD #dyslipidemia pic.twitter.com/UBfKy45mAu
— European Society of Cardiology Journals (@ESC_Journals) January 2, 2023
The year in cardiovascular medicine 2022: the top 10 papers in heart failure and cardiomyopathies
9 Jan, 2023 | 14:10h | UTC
Commentary on Twitter
The Year in Cardiovascular Medicine 2022 series: the Top 10 papers in Heart Failure and Cardiomyopathies https://t.co/w6opcMPcBa@escardio #EHJ #ESCYoung #cardiotwitter @ehj_ed @rladeiraslopes #HeartFailure #Cardiomyopathies pic.twitter.com/UrrX2LUQdI
— European Society of Cardiology Journals (@ESC_Journals) January 2, 2023
The year in cardiovascular medicine 2022: the top 10 papers in cardiovascular imaging
9 Jan, 2023 | 14:21h | UTC
Commentary on Twitter
The Year in Cardiovascular Medicine 2022 series: the Top 10 papers in Acute Cardiac Care and Ischaemic Heart Disease https://t.co/nRNjEyAeDR@escardio #EHJ #ESCYoung #cardiotwitter @ehj_ed @rladeiraslopes #cvacute #ischaemic #heartdisease pic.twitter.com/qCoug19mNJ
— European Society of Cardiology Journals (@ESC_Journals) January 2, 2023
The year in cardiovascular medicine 2022: the top 10 papers in arrhythmias
9 Jan, 2023 | 14:19h | UTCThe year in cardiovascular medicine 2022: the top 10 papers in arrhythmias – European Heart Journal
Commentary on Twitter
The Year in Cardiovascular Medicine 2022 series: the Top 10 papers in Arrhythmias https://t.co/D3GM1l8TgW@escardio #EHJ #ESCYoung #cardiotwitter @ehj_ed @rladeiraslopes #CVD #arrhythmias pic.twitter.com/kxXqyEx8KM
— European Society of Cardiology Journals (@ESC_Journals) January 2, 2023
The year in cardiovascular medicine 2022: the top 10 papers in cardio-oncology
9 Jan, 2023 | 14:08h | UTC
Commentary on Twitter
The Year in Cardiovascular Medicine 2022 series: the Top 10 papers in Cardio-oncology https://t.co/hfWJ94MmxK@escardio #EHJ #ESCYoung #cardiotwitter @ehj_ed @rladeiraslopes @mayocvonc #cardioonco #CVD @TeresaLpezFdez1 pic.twitter.com/30SNvdvkEV
— European Society of Cardiology Journals (@ESC_Journals) January 2, 2023
Phase 1-2 study | Adagrasib with or without Cetuximab in colorectal cancer with mutated KRAS G12C
9 Jan, 2023 | 14:04h | UTCAdagrasib with or without Cetuximab in Colorectal Cancer with Mutated KRAS G12C – New England Journal of Medicine (link to abstract – $ for full-text)
News Release: Advanced Colorectal Cancer Treatment Targets KRAS Gene With Drug Combo – Memorial Sloan Kettering Cancer Center
Commentary on Twitter
In heavily pretreated patients with mutant KRAS G12C colorectal cancer, adagrasib induced a response in 19% as single agent and in 46% in combination with cetuximab, an epidermal growth factor receptor antibody. https://t.co/nCoEPeV9oB pic.twitter.com/FCHxU9WCin
— NEJM (@NEJM) December 21, 2022
Left heart catheterization complications | ED presentations, evaluation, and management
9 Jan, 2023 | 14:07h | UTCLeft Heart Catheterization Complications: ED Presentations, Evaluation, and Management – emDocs
Review | Transmission of Group B Streptococcus in late-onset neonatal disease
9 Jan, 2023 | 14:05h | UTC
M-A | Laparoscopic vs. open pancreatoduodenectomy in patients with periampullary tumors
9 Jan, 2023 | 14:02h | UTCLaparoscopic versus Open Pancreatoduodenectomy in Patients with Periampullary Tumors: A Systematic Review and Meta-analysis – Annals of Surgery (link to abstract – $ for full-text)
M-A | Safety outcomes of direct discharge home from ICUs
9 Jan, 2023 | 14:01h | UTC
Commentary from the author on Twitter (thread – click for more)
Our latest paper on directly discharging patients home from the ICU is now available on @CritCareMed @Pharmastache @_SHRF_ @USaskMedDean https://t.co/WiVgbgWFfr
— Eric Sy (@ericjuliansy) November 10, 2022
RCT | Nonoperative vs. operative treatment for displaced finger metacarpal shaft fractures
9 Jan, 2023 | 13:58h | UTC
M-A | Prediction of difficult laryngoscopy using ultrasound
9 Jan, 2023 | 13:59h | UTCPrediction of Difficult Laryngoscopy Using Ultrasound: A Systematic Review and Meta-Analysis – Critical Care Medicine (link to abstract – $ for full-text)
Happy Holidays! We will return with our activities on January 9, 2023. Any breakthrough articles during this break will be delivered at the beginning of the year.
19 Dec, 2022 | 03:46h | UTCReview | Voice restoration in mechanically ventilated intensive care unit patients with a tracheostomy
9 Jan, 2023 | 13:44h | UTC
WHO manual on sugar-sweetened beverage taxation policies to promote healthy diets.
16 Dec, 2022 | 13:52h | UTCNews Release: WHO calls on countries to tax sugar-sweetened beverages to save lives – World Health Organization
Related:
M-A: Outcomes following taxation of sugar-sweetened beverages.
Public Policies to Reduce Sugary Drink Consumption in Children and Adolescents – Pediatrics
Cutting back on sugar-sweetened beverages: What works? – Cochrane Library
Sugar-sweetened beverage taxes: Lessons to date and the future of taxation – PLOS Medicine
Banning the promotion of soft drinks could be more effective than a sugar tax – The Conversation
Sugar tax: why health experts want it but politicians and industry are resisting – The Guardian
Commentary on Twitter
Sugar is addictive and keeps you hooked on unhealthy drinks like sodas & energy drinks.
Break the cycle today for a healthier life! https://t.co/M1GQE4136I pic.twitter.com/06aVCYmeK5— World Health Organization (WHO) (@WHO) December 13, 2022
RCT | Chlorthalidone (12.5-25 mg) and Hydrochlorothiazide (25-50 mg) are similarly effective for the prevention of CVD in hypertensive patients.
16 Dec, 2022 | 13:49h | UTCChlorthalidone vs. Hydrochlorothiazide for Hypertension–Cardiovascular Events – New England Journal of Medicine (link to abstract – $ for full-text)
Related (news release and commentaries before publication): RCT | Chlortalidone and Hydrochlorothiazide resulted in similar reductions of CVD in older patients with hypertension.
Commentary on Twitter
Patients 65 years or older with hypertension who switched from chlorthalidone to hydrochlorothiazide did not have fewer major cardiovascular events or non–cancer-related deaths than those who continued receiving hydrochlorothiazide. https://t.co/9xAiSZzxio pic.twitter.com/bIVOOiVDve
— NEJM (@NEJM) December 14, 2022


